Search Results 1081-1090 of 16219 for monoclonal antibody

1. Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   No prior chemotherapy, biological response modifiers (e.g., monoclonal antibody therapy), or radiotherapy; At least 28 days since prior corticosteroids ...

2. Publications - Andrew McKeon, M.B., B.Ch., M.D. - Mayo Clinic

   Mangioris G, Orozco E, Dubey D, Flanagan EP, Pittock SJ, Zekeridou A, McKeon A. Long-term outcomes in antibody-negative autoimmune encephalitis: a ...

3. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

4. A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids). Inability ...

5. Stem Cell Therapy Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Giving dendritic cell therapy after ...

6. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   Subject who received any prior monoclonal antibodies against PD-1 or PD-L1 and/or any prior: Arm A only: ImiDs (eg, lenalidomide, thalidomide);; Arm B ...

7. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

8. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

   anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; an anthracycline containing chemotherapy regimen. No evidence ...

9. A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) - Mayo Clinic

   Positive for human immunodeficiency virus (HIV) or hepatitis C antibody. Positive for hepatitis B surface antigen. Splenectomy within 3 months of screening ...

10. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    ... monoclonal antibody (e.g., rituximab) in combination with chemotherapy. Measurable disease as defined below: Fluorodeoxyglucose (FDG)-avid lymphomas ...